AI assistant
Silence Therapeutics plc — Director's Dealing 2025
Jan 2, 2025
33536_dirs_2025-01-02_6966b3b3-5f32-4906-8dac-04b3d1aab546.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Silence Therapeutics plc (SLN)
CIK: 0001479615
Period of Report: 2025-01-02
Reporting Person: TOOMAN CRAIG A (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 33486 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Share Option (Right to Buy) | $7.02 | 2031-01-06 | Ordinary Shares (580000) | Direct | |
| Employee Share Option (Right to Buy) | $7.87 | 2032-01-06 | Ordinary Shares (264999) | Direct | |
| Employee Share Option (Right to Buy) | $6.33 | 2032-02-21 | Ordinary Shares (375000) | Direct | |
| Employee Share Option (Right to Buy) | $3.86 | 2032-09-16 | Ordinary Shares (900000) | Direct | |
| Employee Share Option (Right to Buy) | $5.13 | 2033-01-05 | Ordinary Shares (2100000) | Direct | |
| Employee Share Option (Right to Buy) | $3.33 | 2033-09-14 | Ordinary Shares (216960) | Direct | |
| Employee Share Option (Right to Buy) | $5.90 | 2034-01-04 | Ordinary Shares (650880) | Direct |
Footnotes
F1: One fourth (1/4th) of the shares subject to the option award vested on January 6, 2022, and one twelfth (1/12th) of the remaining shares subject to the option award vested or shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F2: This option vested or shall vest in equal monthly installments over a four-year period measured from one month following January 6, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.
F3: This option vested or shall vest in equal monthly installments over a four-year period measured from one month following February 21, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.
F4: This option vested or shall vest in equal monthly installments over a five-year period measured from one month following September 16, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.
F5: This option vested or shall vest in equal monthly installments over a four-year period measured from one month following January 5, 2023, subject to the Reporting Person's continuous service as of the applicable vesting date.
F6: One fourth (1/4th) of the shares subject to the option vested on September 14, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.
F7: One fourth (1/4th) of the shares subject to the option shall vest on January 4, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.